Pulse Oximeters: A Hidden Bias in Medical Technology
A groundbreaking study published in The BMJ has revealed a concerning issue with pulse oximeters, a common medical device used to monitor blood oxygen levels. These devices, which are widely used in healthcare settings and even at home, may be overestimating blood oxygen levels in patients with darker skin tones, potentially leading to misdiagnosis and delayed treatment.
The study, which analyzed data from 903 critically ill adults, found that pulse oximeters provided higher readings for patients with darker skin tones compared to those with lighter skin tones. This discrepancy can have serious implications, as it may result in low blood oxygen levels being missed in darker-skinned patients, leading to delayed care, while lighter-skinned patients may receive unnecessary treatment.
Pulse oximeters work by measuring the amount of oxygen in the blood (SpO2) using light. However, the study highlights a critical issue: darker skin tones can absorb more light, causing the device to incorrectly interpret higher oxygen levels. This bias has been previously suspected but was challenging to confirm due to the complexity of factors affecting pulse oximeter readings.
To address this, researchers compared the pulse oximetry readings with 'gold-standard' arterial blood gas measurements (SaO2) for each patient. They found that, on average, SpO2 readings were 0.6-1.5 percentage points higher for patients with darker skin tones. This difference is significant, as it can lead to false negatives (missing low oxygen levels) and false positives (indicating low oxygen when it's not present) in the diagnosis of hypoxaemia.
The study's findings emphasize the need for healthcare professionals to interpret pulse oximeter readings with caution, especially for patients with darker skin tones. It also calls for regulatory changes to ensure the equitable use of this technology, preventing it from exacerbating existing inequalities in healthcare.
This research highlights the importance of considering skin tone when using pulse oximeters and underscores the need for further studies to understand and mitigate this bias. As the authors conclude, "The goal is not to abandon pulse oximetry but to understand its limits and make it equitable."
This study serves as a reminder that medical technology, while invaluable, must be used with careful consideration of individual patient characteristics to ensure accurate and fair diagnosis and treatment.
